Acute coronary syndrome

patients with scheduled percutaneous coronary intervention 0 trials

patients with a recent ACS 6 trials

all type of patients 89 trials

unstable angina 1 trials

patients managed with an early invasive strategy 2 trials

PCI sub group 3 trials

Acute myocardial infarction

patients with scheduled percutaneous coronary intervention 0 trials

all type of patients 36 trials

Atrial fibrillation

primary prevention of thromboembolic events 47 trials

secondary prevention of thromboembolic events 7 trials

patients ineligible for warfarin 2 trials

Cardiovascular prevention

primary prevention 8 trials

secondary prevention 7 trials

patienst at high risk 5 trials

all type of patients 14 trials

diabetic patients 0 trials

Diabetes type 2

patient without history of atherosclerotic disease 0 trials

DVT prophylaxis

patients with cancer 0 trials

patients with immobilization of the lower extremities 7 trials

patients with myocardial infarction 8 trials

medical patients 33 trials

general surgery 135 trials

urologic surgery 8 trials

gynaecological surgery 6 trials

oncolgical surgery 0 trials

abdominal surgery 32 trials

neurosurgery 4 trials

arthroscopy 7 trials

immobilisation by cast 0 trials

orthopedic surgery 160 trials

elective major knee surgery 18 trials

elective hip replacement 48 trials

hip Fracture 7 trials

Heart failure

patients hospitalized for heart failure 1 trials

all type of patients 8 trials

Percutaneous coronary intervention

all type of patients 62 trials

patients with high residual platelet activity on clopidogrel 1 trials

PCI with stent placement 23 trials

MI patients undergoing primary PCI 2 trials

Peripheral vascular diseases

all type of patients 7 trials

after revascularisation 13 trials

Post acute coronary syndromes

all type of patients 1 trials

Post myocardial infarction

all type of patients 1 trials

Pulmonary embolism

all type of patients 22 trials

Stable angina

all type of patient 15 trials

Stent

all type of patients 28 trials

antiplatelet therapy after stent placement (BMS) 0 trials

antiplatelet therapy after stent placement (DES) 0 trials

Superficial thrombophlebitis

superficial thrombophlebitis of the leg 40 trials

Venous thrombosis

all type of patients 71 trials

patients with cancer 9 trials

secondary prevention of VTE 16 trials